PDF(Pubmed)
Abstract：
Cameroon introduced the malaria vaccine in its routine immunization program on 22 January 2024 in the 42 districts out of 200 that are among the most at risk of malaria. A cross-sectional analysis of the data on key vaccine events in the introduction roadmap and the vaccine uptake during the first 30 days was conducted. In addition to available gray literature related to the introduction of the malaria vaccine, data on the malaria vaccine uptake by vaccination session, collected through a digital platform, were analyzed. A total of 1893 reports were received from 22 January 2024 to 21 February 2024 from 766 health facilities (84% of overall completeness). Two regions out of ten recorded less than 80% completeness. As of 21 February 2024, 13,811 children had received the first dose of the malaria vaccine, including 7124 girls (51.6%) and 6687 boys (48.4%). In total, 36% of the children were vaccinated through outreach sessions, while 61.5% were vaccinated through sessions in fixed posts. The overall monthly immunization coverage with the first dose was 37%. Early results have shown positive attitudes towards and acceptance of malaria vaccines. Suboptimal completeness of data reporting and a low coverage highlight persistent gaps and challenges in the vaccine rollout.
摘要：
喀麦隆于2024年1月22日在200个疟疾风险最大的地区中的42个地区的常规免疫计划中引入了疟疾疫苗。对引入路线图中的关键疫苗事件数据和前30天的疫苗摄取进行了横截面分析。除了与引入疟疾疫苗有关的可用灰色文献外，疫苗接种会议对疟疾疫苗的吸收数据，通过数字平台收集，进行了分析。从2024年1月22日至2024年2月21日，共收到766个医疗机构的1893份报告（占总体完整性的84%）。十个区域中有两个记录的完整性小于80%。截至2024年2月21日，13811名儿童接种了第一剂疟疾疫苗，包括7124名女孩(51.6%)和6687名男孩(48.4%)。总的来说,36%的儿童通过外展会议接种了疫苗，而61.5%的人通过固定岗位的会议接种疫苗。第一剂的总每月免疫覆盖率为37%。早期结果显示了对疟疾疫苗的积极态度和接受。数据报告的次优完整性和低覆盖率突出了疫苗推广中的持续差距和挑战。
